![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Bauer, Axel; Schreinlechner, Michael; Sappler, Nikolay; Dolejsi, Theresa; Tilg, Herbert; Aulinger, Benedikt A.; Weiss, Günter; Bellmann-Weiler, Rosa; Adolf, Christian; Wolf, Dominik; Pirklbauer, Markus; Graziadei, Ivo; Gänzer, Hannes; von Bary, Christian; May, Andreas E.; Wöll, Ewald; Scheidt, Wolfgang von; Rassaf, Tienush; Duerschmied, Daniel; Brenner, Christoph; Kääb, Stefan; Metzler, Bernhard; Joannidis, Michael; Kain, Hans-Ulrich; Kaiser, Norbert; Schwinger, Robert; Witzenbichler, Bernhard; Alber, Hannes; Straube, Florian; Hartmann, Niels; Achenbach, Stephan; Bergwelt-Baildon, Michael von; Stülpnagel, Lukas von; Schoenherr, Sebastian; Forer, Lukas; Embacher-Aichhorn, Sabine; Mansmann, Ulrich 
ORCID: https://orcid.org/0000-0002-9955-8906; Rizas, Konstantinos D. und Massberg, Steffen
(2021):
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
In: The Lancet. Respiratory medicine
ORCID: https://orcid.org/0000-0002-9955-8906; Rizas, Konstantinos D. und Massberg, Steffen
(2021):
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
In: The Lancet. Respiratory medicine
Barco, Stefano; Schmidtmann, Irene; Ageno, Walter; Anusic, Toni; Bauersachs, Rupert M.; Becattini, Cecilia; Bernardi, Enrico; Beyer-Westendorf, Jan; Bonacchini, Luca; Brachmann, Johannes; Christ, Michael; Czihal, Michael; Duerschmied, Daniel; Empen, Klaus; Espinola-Klein, Christine; Ficker, Joachim H.; Fonseca, Candida; Genth-Zotz, Sabine; Jimenez, David; Harjola, Veli-Pekka; Held, Matthias; Prat, Lorenzo Iogna; Lange, Tobias J.; Lankeit, Mareike; Manolis, Athanasios; Meyer, Andreas; Muenzel, Thomas; Mustonen, Pirjo; Rauch-Kroehnert, Ursula; Ruiz-Artacho, Pedro; Schellong, Sebastian; Schwaiblmair, Martin; Stahrenberg, Raoul; Valerio, Luca; Westerweel, Peter E.; Wild, Philipp S. und Konstantinides, Stavros V.
(2021):
Survival and quality of life after early discharge in low-risk pulmonary embolism.
In: European Respiratory Journal, Bd. 57, Nr. 2, 2002368
Bauer, Axel; Schreinlechner, Michael; Sappler, Nikolay; Dolejsi, Theresa; Tilg, Herbert; Aulinger, Benedikt A.; Weiss, Guenter; Bellmann-Weiler, Rosa; Adolf, Christian; Wolf, Dominik; Pirklbauer, Markus; Graziadei, Ivo; Gaenzer, Hannes; Bary, Christian von; May, Andreas E.; Woell, Ewald; Scheidt, Wolfgang von; Rassaf, Tienush; Duerschmied, Daniel; Brenner, Christoph; Kaeaeb, Stefan; Metzler, Bernhard; Joannidis, Michael; Kain, Hans-Ulrich; Kaiser, Norbert; Schwinger, Robert; Witzenbichler, Bernhard; Alber, Hannes; Straube, Florian; Hartmann, Niels; Achenbach, Stephan; Bergwelt-Baildon, Michael von; Stuelpnagel, Lukas von; Schoenherr, Sebastian; Forer, Lukas; Embacher-Aichhorn, Sabine; Mansmann, Ulrich; Rizzast, Konstantinos D. und Massberg, Steffen
(2021):
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial.
In: Lancet Respiratory Medicine, Bd. 9, Nr. 8: S. 863-872
Barco, Stefano; Schmidtmann, Irene; Ageno, Walter; Bauersachs, Rupert M.; Becattini, Cecilia; Bernardi, Enrico; Beyer-Westendorf, Jan; Bonacchini, Luca; Brachmann, Johannes; Christ, Michael; Czihal, Michael; Duerschmied, Daniel; Empen, Klaus; Espinola-Klein, Christine; Ficker, Joachim H.; Fonseca, Candida; Genth-Zotz, Sabine; Jimenez, David; Harjola, Veli-Pekka; Held, Matthias; Prat, Lorenzo Iogna; Lange, Tobias J.; Manolis, Athanasios; Meyer, Andreas; Mustonen, Pirjo; Rauch-Kroehnert, Ursula; Ruiz-Artacho, Pedro; Schellong, Sebastian; Schwaiblmair, Martin; Stahrenberg, Raoul; Westerweel, Peter E.; Wild, Philipp S.; Konstantinides, Stavros V. und Lankeit, Mareike
(2020):
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
In: European Heart Journal, Bd. 41, Nr. 4: S. 509-518